2. Vive Summary Vive reformulates existing pesticides for the $46 Billion crop protection industry, addressing issues jeopardizing the industry Replace organic solvents with biodegradable or bio-inert polymers Working with six global crop protection companies on products with $8 billion total addressable market Six products in field trials with results expected by year end Trials demonstrate Vive formulations are more effective than current products Products and process are patented and are 100% owned Experienced management team and advisors Raised $16 MM to date 2

3. 3 Crop Yields are a Worldwide Issue Population growth Shrinking arable land Changing diets Biofuels $ 46B pesticide industry The Growing Use of Pesticides is Assured

4. Yet Industry Profits are Under Pressure Patent Cliff Lack of New Molecules Regulatory Barriers Crop Protection Industry Syngenta | Bayer | BASF | DuPont | Dow Pressure from Generics 4

5. Addressing Crop Protection Industry’s Key Issues PatentableCompetitiveApprovable New IP without new active ingredient Economics Efficacy Convenience Grower safety Avoid toxic formulations Environmental safety 5 Products

6. Vive Patented Technology Platform IP GeneratingInnovativeApprovable Broadly applicable reformulation technology Lower development cost per product Improves economics, efficacy, safety, convenience Fast timelines Improves handling and safety Enables water to act as the only solvent 6

7. Active Ingredient (AI)Vive CageVive New Product Vive Technology Not soluble in waterEncapsulates AI in a water dispersible (non-toxic) structure Encapsulated AI dispersed in water 77

8. Vive Technology Platform Water and bio-inert polymers create a cage that delivers the active ingredient 8

9. Low capital cost — uses off the shelf equipment Main inputs are EPA approved polymers Straightforward path to large commercial scale $4 MM capex for 200T Allosperse plant Pilot Scale Plant (Five tonnes per year) Simple, Scalable Manufacturing 9 9

10. 10 6,000 Tonnes of packaged product with >$100 MM in annual revenue Vive 200 Tonne plant Low Capex with Significant Product Leverage 600 Tonnes of partner supplied active ingredient

11. 12 issued patents (first expiry 2017) 52 patents pending 7 families in the US and internationally New products via patentable reformulations First reformulated product patents to be filed in 2012 Four Levels of IP Protection Patent Cliff Ongoing IP Generation 11 Product IP Application IP Process IP Composition of Matter IP

12. Patented ActivesGeneric Actives Developing products with branded companies $5 Billion+ addressable market Upfront, milestone and royalty revenue Developing products to be distributed through branded companies $3 Billion+ addressable market Product revenue Portfolio Renewal and Extension Model 12 Vive Product Portfolio

13. Partnered Product 13 Improved Insecticide Efficacy TreatmentPests Killed Plant Damage (Lower is Better) Vive90%1.1% Ammo5%32.5% Third party trials tested Vive’s formulated cypermethrin versus the leading competitive product, FMC’s Ammo Both products were applied at 0.1ppm Tests demonstrated superior performance killing pests and protecting plants Results have been confirmed in 5 different trials What Does it Mean to the Farmer? Potential product benefits include: Better plant protection – higher yields Buy and use less pesticide – save money Vive’s formulation was 18x more effective killing pests and ~30x more effective protecting plants from insect damage

14. Partnered Product 14 Improved Residual Activity Trials test how long a product keeps working after it is applied Third party trials tested Vive’s formulated lambda-cyhalothrin versus the leading premium product, Syngenta’s Karate Zeon, at identical concentrations Karate Zeon is marketed against “standard” products based on its superior residual activity Results show that Vive’s formulation is better after 7 and 14 days What Does it Mean to the Farmer? Potential product benefits include: Sustained protection – higher yields, better crops Apply less often – save money and hassle TreatmentPests Killed 7 Days Later Pests Killed 14 Days Later Vive90%76% Karate Zeon50%42% Vive’s formulation was 80% more effective killing pests both one and two weeks after application

15. Potential Markets 15 Pharmaceuticals TAM => $500 Bn Beauty and Personal Care TAM => $425 Bn Crop Protection TAM => $50 Bn Nutritionals TAM => $100 Bn Industrial TAM => $300 Bn Potential Markets > $1 Trillion

16. Corporate Information 16

17. Keith Thomas CEO Entrepreneur, project management and corporate finance; Booz Allen, Citigroup, BASc (Toronto), MA (Toronto), MBA (Columbia) Darren Anderson CTO Founding president, 4 issued patents, 24 pending applications, 10 refereed papers, over 40 conference presentations and publications, PhD (Toronto) Flavio Campagnaro VP Manufacturing Senior process engineer, scaled large environmental plants; Bennett Environmental, BASc (UBC), PEng Skip Campbell VP Product Creation Boston-based M&A and advisory for high-tech industries, consulting and VC experience, BA (Williams), MBA (Toronto) Ken Yoon CFO and VP Corp Development Life sciences venture capitalist, consulting and accounting; VenGrowth, Ernst & Young, BSc (Western), LLB (Queen’s), MBA (Toronto), CA Management 17 Supplemented by 10 advisors with experience at Syngenta, BASF, DuPont, Dow, FMC,etc.

18. Neil Reid Chair Co-founder, MDS Sciex Charlie Fischer Director Former CEO, Dow AgroSciences; Former Chair, CropLife America and CropLife International Warren Libby Director Former President, Syngenta Canada; Former Chairman, Crop Protection Institute of Canada Bill Lambert Director Chairman, Ag Growth International; Former Partner, TD Capital Mark MacDonald Director Former VP, Teachers Private Equity; significant board experience Directors 18

19. The Vive Opportunity $46 Billion global market opportunity with assured demand with significant potential in additional markets Patent cliff, formulation issues and generics are unavoidable Disruptive, patented, green technology addresses industry needs Products with $8 Billion addressable market in dev and trials Strong management team and directors Commercial deals in 2013 and product launches in 2014 19